![Patrick Loustau](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Patrick Loustau
Nessuna posizione attualmente
Storia della carriera di Patrick Loustau
Precedenti posizioni note di Patrick Loustau
Società | Posizione | Inizio | Fine |
---|---|---|---|
LARIMAR THERAPEUTICS, INC. | Presidente | 01/07/2014 | 19/07/2016 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/08/2010 | 01/04/2014 |
NOVO NORDISK A/S | Corporate Officer/Principal | 01/07/1996 | 01/07/2010 |
Formazione di Patrick Loustau
Statistiche
Distribuzione geografica
Stati Uniti | 3 |
Danimarca | 2 |
Francia | 2 |
Posizioni
Corporate Officer/Principal | 2 |
President | 1 |
Graduate Degree | 1 |
Settori
Health Technology | 4 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
NOVO NORDISK A/S | Health Technology |
Aziende private | 2 |
---|---|
Zafgen, Inc.
![]() Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
Université de Paris XI Paris Sud | Consumer Services |
- Borsa valori
- Insiders
- Patrick Loustau
- Esperienza